AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.77+0.55 (+3.61%)
Close on Nov 17, 2026Market cap $487.72MP/E –Yield –
AVITA Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AVITA Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$24.23M. For fiscal 2025 it was -$31.20M. The highest annual figure on record is -$12.96M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$31.20M | – |
| FY2024 | Dec 31, 2024 | -$48.90M | – |
| FY2023 | Dec 31, 2023 | -$38.01M | – |
| FY2021 | Jun 30, 2021 | -$25.90M | – |
| FY2020 | Jun 30, 2020 | -$22.75M | – |
| FY2019 | Jun 30, 2019 | -$19.25M | – |
| FY2018 | Jun 30, 2018 | -$12.96M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$3.50M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$10.07M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$5.44M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$5.22M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$10.23M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$10.31M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$8.04M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$7.21M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$12.78M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$20.86M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$10.86M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$8.97M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$9.10M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$9.07M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$3.95M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$8.54M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$5.68M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$7.71M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$5.92M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$7.30M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$4.65M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$4.88M | – |
See a number that looks wrong?